![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 12, 9800-9805, March 22, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Pathology, Harvard Medical School, Boston,
Massachusetts 02115
Connective tissue growth factor (CTGF) is
abundantly expressed in the vascular smooth muscle cells (VSMC) of
atherosclerotic lesions but not in normal vessels. CTGF is able to
promote VSMC proliferation and migration and influences the composition
of extracellular matrix. The mechanisms for controlling these
events remain unclear. We studied the effects of CTGF on matrix
metalloproteinases (MMPs) by introducing a CTGF
over-expression construct into VSMC. We found that the
over-expression of CTGF significantly increased the activity of MMP-2
in VSMC conditioned medium. MMP-2 activity was similarly increased by
exogenous CTGF treatment, and this effect could be blocked by an
anti-CTGF antibody. We also showed that the increased MMP-2 activity
was due to an increase in MMP-2 mRNA levels in VSMC. We further
studied the mechanisms involved in the regulation of MMP-2 mRNA
levels and found that the AP-2 transcription factor is responsible for
most of the CTGF-induced MMP-2 transcription. Because MMP-2 is an
important factor directly involved in controlling cell movement and the
turnover of extracellular matrix, our study may provide a mechanism for
CTGF-promoted VSMC migration.
Increased MMP-2 Expression in Connective Tissue Growth Factor
Over-expression Vascular Smooth Muscle Cells*
and
*
This work was supported by Grant HL17747 from the NHLBI,
National Institutes of Health (Bethesda, MD).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed. Fax: 617-432-2793;
E-mail: wenhuafan@hms.harvard.edu.
This article has been cited by other articles:
![]() |
S. He, Y. Chen, R. Khankan, E. Barron, R. Burton, D. Zhu, S. J. Ryan, N. Oliver, and D. R. Hinton Connective Tissue Growth Factor as a Mediator of Intraocular Fibrosis Invest. Ophthalmol. Vis. Sci., September 1, 2008; 49(9): 4078 - 4088. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Ning, Y. Dong, J. Sun, C. Li, M. A. Matthay, C. A. Feghali-Bostwick, and A. M. K. Choi Cigarette Smoke Stimulates Matrix Metalloproteinase-2 Activity via EGR-1 in Human Lung Fibroblasts Am. J. Respir. Cell Mol. Biol., April 1, 2007; 36(4): 480 - 490. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Han, J. D. Ritzenthaler, B. Wingerd, H. N. Rivera, and J. Roman Extracellular Matrix Fibronectin Increases Prostaglandin E2 Receptor Subtype EP4 in Lung Carcinoma Cells through Multiple Signaling Pathways: THE ROLE OF AP-2 J. Biol. Chem., March 16, 2007; 282(11): 7961 - 7972. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Cummins, N. von Offenberg Sweeney, M. T. Killeen, Y. A. Birney, E. M. Redmond, and P. A. Cahill Cyclic strain-mediated matrix metalloproteinase regulation within the vascular endothelium: a force to be reckoned with Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H28 - H42. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Cheng, A. S. Pollock, R. Mahimkar, J. L. Olson, and D. H. Lovett Matrix metalloproteinase 2 and basement membrane integrity: a unifying mechanism for progressive renal injury FASEB J, September 1, 2006; 20(11): 1898 - 1900. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kodali, M. Hajjou, A. B. Berman, M. B. Bansal, S. Zhang, J. J. Pan, and A. D. Schecter Chemokines induce matrix metalloproteinase-2 through activation of epidermal growth factor receptor in arterial smooth muscle cells Cardiovasc Res, February 15, 2006; 69(3): 706 - 715. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. V. McLennan, X. Y. Wang, V. Moreno, D. K. Yue, and S. M. Twigg Connective Tissue Growth Factor Mediates High Glucose Effects on Matrix Degradation through Tissue Inhibitor of Matrix Metalloproteinase Type 1: Implications for Diabetic Nephropathy Endocrinology, December 1, 2004; 145(12): 5646 - 5655. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Pellikainen, K. M. Ropponen, V. V. Kataja, J. K. Kellokoski, M. J. Eskelinen, and V.-M. Kosma Expression of Matrix Metalloproteinase (MMP)-2 and MMP-9 in Breast Cancer with a Special Reference to Activator Protein-2, HER2, and Prognosis Clin. Cancer Res., November 15, 2004; 10(22): 7621 - 7628. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.H. Tayebjee, G.Y.H. Lip, and R.J. MacFadyen Collateralization and the response to obstruction of epicardial coronary arteries QJM, May 1, 2004; 97(5): 259 - 272. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Bonniaud, P. J. Margetts, M. Kolb, T. Haberberger, M. Kelly, J. Robertson, and J. Gauldie Adenoviral Gene Transfer of Connective Tissue Growth Factor in the Lung Induces Transient Fibrosis Am. J. Respir. Crit. Care Med., October 1, 2003; 168(7): 770 - 778. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.-W. Wang, H. Chang, S. Lin, P. Kuan, and K.-G. Shyu Induction of matrix metalloproteinases-14 and -2 by cyclical mechanical stretch is mediated by tumor necrosis factor-{alpha} in cultured human umbilical vein endothelial cells Cardiovasc Res, August 1, 2003; 59(2): 460 - 469. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ivkovic, B. S. Yoon, S. N. Popoff, F. F. Safadi, D. E. Libuda, R. C. Stephenson, A. Daluiski, and K. M. Lyons Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development Development, June 15, 2003; 130(12): 2779 - 2791. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Burgess, P. R. A. Johnson, Q. Ge, W. W. Au, M. H. Poniris, B. E. McParland, G. King, M. Roth, and J. L. Black Expression of Connective Tissue Growth Factor in Asthmatic Airway Smooth Muscle Cells Am. J. Respir. Crit. Care Med., January 1, 2003; 167(1): 71 - 77. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Wahab, B. S. Weston, T. Roberts, and R. M. Mason Connective Tissue Growth Factor and Regulation of the Mesangial Cell Cycle: Role in Cellular Hypertrophy J. Am. Soc. Nephrol., October 1, 2002; 13(10): 2437 - 2445. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |